BeOne Medicines AG
OTC:BEIGF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BeOne Medicines AG
OTC:BEIGF
|
CH |
|
Grupa Azoty SA
F:5PL
|
PL |
|
Poste Italiane SpA
MIL:PST
|
IT |
|
H
|
HEICO Corp
F:HC1
|
US |
Intrinsic Value
Is BEIGF undervalued or overvalued?
See the intrinsic value estimate for
BeOne Medicines AG and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What BeOne Medicines Does
BeiGene is a cancer drug company that discovers, develops, manufactures, and sells medicines for oncology. Its best-known products are targeted therapies and immunotherapies used to treat different kinds of blood cancers and solid tumors. The company also runs clinical trials to find new drug candidates and expand the uses of its existing medicines.
- Headquarters
- Switzerland CH
- Employees
- 12 000
- IPO date
- Mar 2, 2016
Earnings Waterfall
BeOne Medicines AG
The intrinsic value for
BeOne Medicines AG (BEIGF) under the Base Case is hidden USD.
Compared with the current market price of 21.946 USD, the stock appears hidden.